CVR: 19995607
Previous names: PBH 25.376 ApS
DKK 3,402,201
Gross profit
Net result: DKK 2,670,973
LEV-VEL ApS, NLDB Holding ApS
CVR · view ownership and management
Director role ended: Ole Birch
CVR · 27/06/2024
View the full event history
OBA-PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PBH 25.376 ApS. The management consists of Malene Dybdahl Birch. The company is owned by LEV-VEL ApS and NLDB Holding ApS. The company has 0 employees (2000). In 2024, the company reported a gross profit of DKK 3,402,201 and a net result of DKK 2,670,973 compared with DKK 2,073,440 the year before. Equity in the 2024 report amounted to DKK 674,251.
Source: annual report 2024, Danish Business Authority
OBA-PHARMA ApS demonstrates a strong financial health trajectory, with consistent growth in gross profit and profit over the past few years. In 2024, the company achieved a gross profit of 3,402,201 DKK and a profit of 2,670,973 DKK, reflecting a notable increase from 2,073,440 DKK in profit in 2023. However, the equity position has declined significantly from 2,244,768 DKK in 2023 to 674,251 DKK in 2024, raising concerns about long-term financial stability. The absence of revenue figures makes it challenging to assess overall market position, but the increasing profit margins indicate effective cost management within the pharmaceutical wholesale industry.
AI-generated summary · Generated 15/08/2026
Selskabets formål er handel og investering og dermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202401/10/2023 – 30/09/2024 | 3.4 mio. | 2.7 mio. | 5.9 mio. | 674 t. | 0 | |
| 202301/10/2022 – 30/09/2023 | 2.9 mio. | 2.1 mio. | 11.6 mio. | 2.2 mio. | 0 | |
| 202201/10/2021 – 30/09/2022 | 1 mio. | 752 t. | 6.6 mio. | 1.9 mio. | 0 | |
| 202101/10/2020 – 30/09/2021 | 1.3 mio. | 1 mio. | 4.9 mio. | 2.2 mio. | 0 | |
| 202001/10/2019 – 30/09/2020 | 1.1 mio. | 865 t. | 3.2 mio. | 1.2 mio. | 0 | |
| 201901/10/2018 – 30/09/2019 | 2.3 mio. | 1.8 mio. | 4.5 mio. | 2.3 mio. | - | |
| 201801/10/2017 – 30/09/2018 | 2.5 mio. | 2.1 mio. | 8.8 mio. | 6.5 mio. | - | |
| 201701/10/2016 – 30/09/2017 | 2.8 mio. | 2.2 mio. | 6.7 mio. | 4.4 mio. | - | |
| 201601/10/2015 – 30/09/2016 | 2.8 mio. | 2.2 mio. | 5.5 mio. | 2.8 mio. | - | |
| 201501/10/2014 – 30/09/2015 | 3.2 mio. | 2.5 mio. | 5.3 mio. | 3.1 mio. | - | |
| 201401/10/2013 – 30/09/2014 | 3.7 mio. | 3.1 mio. | 6.6 mio. | 3.6 mio. | - | |
| 201301/10/2012 – 30/09/2013 | 2.9 mio. | 2.4 mio. | 5.7 mio. | 3 mio. | - | |
| 201201/10/2011 – 30/09/2012 | 3 mio. | 2.2 mio. | 10.2 mio. | 7.6 mio. | - |
Compared to 407 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreOBA-PHARMA ApS was founded on 1 April 1997.
OBA-PHARMA ApS is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler (industry code 464610).
OBA-PHARMA ApS had 0 employees in 2000 according to the Danish CVR register.
OBA-PHARMA ApS is owned by LEV-VEL ApS and NLDB Holding ApS.
In 2024, OBA-PHARMA ApS reported a gross profit of DKK 3,402,201.
The management of OBA-PHARMA ApS consists of Malene Dybdahl Birch.
Claim this page to add your logo and social links. Free to get started.
Address changed to Sølvgade 23 st., 1307 København K (April 9, 2026).
Contact info changed: new phone: 33326647 (April 9, 2026).
Address changed to Sølvgade 23 kl., 1307 København K (April 7, 2026).
Contact info changed: new phone: 33326647 (April 7, 2026).
OBA-PHARMA ApS has published its interim report for the period October 1, 2024 – June 30, 2025.
OBA-PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 3,402,201, and the net result was DKK 2,670,973.
As of June 27, 2024, Malene Dybdahl Birch is registered as director of OBA-PHARMA ApS.
As of June 27, 2024, Ole Birch has stepped down as director of OBA-PHARMA ApS.
As of June 27, 2024, LEV-VEL ApS is registered as an owner of OBA-PHARMA ApS with an ownership share of 50%.
As of June 27, 2024, NLDB Holding ApS is registered as an owner of OBA-PHARMA ApS with an ownership share of 50%.
OBA-PHARMA ApS has published its annual report for 2023. Gross profit came to DKK 2,852,775, and the net result was DKK 2,073,440.
OBA-PHARMA ApS has published its annual report for 2022. Gross profit came to DKK 1,041,316, and the net result was DKK 752,443.
OBA-PHARMA ApS has published its annual report for 2021. Gross profit came to DKK 1,333,640, and the net result was DKK 1,001,773.
OBA-PHARMA ApS has published its annual report for 2020. Gross profit came to DKK 1,119,532, and the net result was DKK 865,029.
OBA-PHARMA ApS has published its annual report for 2019. Gross profit came to DKK 2,252,532, and the net result was DKK 1,803,661.
OBA-PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 2,521,605, and the net result was DKK 2,069,878.
OBA-PHARMA ApS has published its annual report for 2017. Gross profit came to DKK 2,770,857, and the net result was DKK 2,155,159.
OBA-PHARMA ApS has published its annual report for 2016. Gross profit came to DKK 2,809,440, and the net result was DKK 2,206,997.
As of February 3, 2017, BHA STATSAUTORISERET REVISION APS has been appointed auditor of OBA-PHARMA ApS.
OBA-PHARMA ApS has published its annual report for 2015. Gross profit came to DKK 3,225,695, and the net result was DKK 2,490,654.
OBA-PHARMA ApS has published its annual report for 2014. Gross profit came to DKK 3,664,804, and the net result was DKK 3,119,719.
OBA-PHARMA ApS has published its annual report for 2013. Gross profit came to DKK 2,900,864, and the net result was DKK 2,356,113.
OBA-PHARMA ApS has published its annual report for 2012. Gross profit came to DKK 2,970,531, and the net result was DKK 2,212,524.
As of November 19, 1999, Kurt Madsen has stepped down as auditor of OBA-PHARMA ApS.
On July 29, 1997, the company changed its name from PBH 25.376 ApS to OBA-PHARMA ApS.
As of July 28, 1997, Kurt Madsen has been appointed auditor of OBA-PHARMA ApS.
As of July 28, 1997, Harry Aamann has stepped down as auditor of OBA-PHARMA ApS.
As of July 28, 1997, Ole Birch is registered as director of OBA-PHARMA ApS.
As of July 28, 1997, Preben Bang Henriksen has stepped down as director of OBA-PHARMA ApS.
As of April 1, 1997, Harry Aamann has been appointed auditor of OBA-PHARMA ApS.
As of April 1, 1997, Preben Bang Henriksen is registered as director of OBA-PHARMA ApS.
OBA-PHARMA ApS was founded on April 1, 1997.
Companies in the same industry and area
CVR 35451307
CVR 19064301
CVR 37726508
CVR 19835081
CVR 21327581
